Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Low Dose Tirofiban for PPCI in STEMI
NCT03797729Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- May 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirofiban in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: TIMI Flow Grade III and TIMI Myocardial Perfusion Grade III. Status: unknown.
02
Drugs
tirofiban
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03797729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797729.